Loading...
Symbols:
Loading...
Symbols:
(CYTX)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on (CYTX)
13 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on CYTX
- Mike Havrilla(9)
- SA Editor Eli Hoffmann(1)
- Centient Biotech Investor(1)
- Sara Calabro(1)
- Ketan Desai (1)
Most popular authors
(tracked in watchlists)
- SA Editor Eli Hoffmann(379)
- Mike Havrilla(83)
- Ketan Desai (13)
- Centient Biotech Investor(3)
- Sara Calabro(0)
Most commented on authors
- Mike Havrilla(23)
- Ketan Desai (12)
- SA Editor Eli Hoffmann(5)
- Centient Biotech Investor(0)
- Sara Calabro(0)
- Regenerative Medicine: Big Pharma's Next Frontier
- Cytori Therapeutics: Soon to Be Sold to Olympus?
- Industry Profile: Cosmetic and Reconstructive Medicine
- Cytori Raises Cash and Announces Second Quarter Results
- Cytori Therapeutics: The Stem Cell 'Celution' for Success
- 10 Biotechs in Stem Cells that Could Profit Under the Democrats
- 5 Emerging Healthcare Stock Picks for 2008
- Cytori Therapeutics Executes its 'Celution' for Commercial Success
- My Top Four Emerging Micro-Cap Biotech Stocks
- Cytori Therapeutics: The 'Celution' for Commercial Success
- Cytori Prefers Stem Cell Devices To Drugs
- How to Profit from Stem Cell R&D - Barron's
- Biotech Stocks Day-In-Review: Amgen Disappoints After The Bell
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »